ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Recommended monitoring during mitotane treatment*

Recommended monitoring during mitotane treatment*
Parameter Interval Comment
Mitotane blood level Every 4 to 6 weeks Target: 14 to 20 mcg/mL (mg/L).
Adverse effects At every visit (initially, every 4 weeks; after 6 months, every 8 weeks) Gastrointestinal adverse effects: Use antiemetics (eg, metoclopramide or a 5-HT3 blocker) or loperamide.
ACTH Suspected glucocorticoid deficiency or excess

CNS side effects (ataxia, confusion, speech or visual problems): Interrupt therapy or reduce dosage. Glucocorticoid status is difficult to determine.

Target: ACTH in the normal range or slightly above. Because of an increased glucorticoid clearance, high-dose glucocorticoid replacement is needed (most patients require at least 50 mg hydrocortisone per day).
Serum sodium and potassium At every visit  
24-hour urine free cortisol At every visit Aim for mid-normal range.
GOT, GPT, bilirubin, GGT Initially, every 4 weeks; after 6 months, every 8 weeks GGT is invariably elevated without clinical consequences. If other liver enzymes are rapidly increasing (greater than threefold of baseline), there is risk of liver failure: Stop mitotane.
TSH, fT3, fT4 Every 3 to 4 months Disturbance of thyroid hormones is frequent. Thyroid hormone replacement is recommended in patients with clinical symptoms of hypothyroidism and low fT4 values.
Testosterone Every 3 to 4 months Hypogonadism frequently occurs. Replacement should be initiated in men with symptoms of hypogonadism.
Renin Every 6 months If renin is elevated, add fludrocortisone.
Cholesterol (HDL, LDL), triglycerides Every 3 to 4 months (in an adjuvant setting) If LDL or HDL cholesterol are highly elevated, consider treatment with statins.
Blood count Every 3 to 4 months Check for relevant leucopoenia, thrombocytopoenia, and anaemia (rare).
5-HT3: 5-hydroxytryptamine; ACTH: corticotropin; CNS: central nervous system; GOT: glutamic-oxaloacetic transaminase; GPT: glutamate pyruvate transaminase; GGT: gamma glutamyltransferase; TSH: thyroid-stimulating hormone; fT3: free triiodothyronine; fT4: free thyroxine; HDL: high-density lipoprotein; LDL: low-density lipoprotein.
* Adapted from: Fassnacht M, Johanssen S, Quinkler M, et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: Proposal for a revised TNM classification. Cancer 2009; 115:243.
¶ In the first 3 months, mitotane blood levels should be checked every 2 to 3 weeks. After reaching a plateau, the interval can be extended.
Original figure modified for this publication. Zini L, Porpiglia F, Fassnact M. Contemporary management of adrenocortical carcinoma. Eur Urol 2011; 60:1055. Table used with the permission of Elsevier Inc. All rights reserved.
Graphic 83932 Version 6.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟